AzTrials
AzTrials

Anorexia NervosaNCT05753410

App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa

A study testing Mindful Courage in people with Anorexia Nervosa and Bulimia Nervosa, run by Yeshiva University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We will evaluate the acceptability and feasibility of a 8-week long digital mindfulness-based intervention for anorexia nervosa and bulimia nervosa. This study is a prospective single-arm trial during the intervention development phase. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Mindful Courage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
1 Mar 2023to 1 Jan 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • Can read and write in English
  • Meet diagnostic DSM 5 diagnostic criteria for anorexia nervosa, bulimia nervosa, or atypical anorexia nervosa/bulimia nervosa
  • Owns a smartphone
  • Willing and able to participate in an eight-week long research study
  • Have a private quiet space at home or headphones to complete modules
  • Completed one month or more of eating disorder treatment
  • Currently enrolled in eating disorder treatment

Who cannot join

  • Fail to meet above-listed inclusion criteria
  • Current alcohol or drug dependence
  • Current untreated psychotic or bipolar disorder
  • Current suicidal intent
  • Significant cognitive impairment that would impair the ability to use Mindful Courage effectively
  • BMI <15 or medically unstable
  • Currently receiving residential/inpatient treatment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Margaret Sala

    The Bronx, New York, 10461-1915

Other trials in United States

About this study

Official title: Feasibility and Acceptability of an App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa

We will evaluate the acceptability and feasibility of a 8-week long digital mindfulness-based intervention for anorexia nervosa and bulimia nervosa.

This study is a prospective single-arm trial during the intervention development phase. Following this phase, after the intervention has been further developed, a subsequent study (with a different clinicaltrials.gov identification #) will utilize a randomized control trial design.

Read the detailed description

Procedures include completing: (1) pre-intervention screening assessment; (2) brief daily assessments for the first and last weeks of the study (4 times per day); (3) an initial baseline visit; (4) 8-week web-based intervention (3) a post-intervention assessment (8-weeks after baseline); and (4) a brief 8-week follow-up assessment.

Being tested
Mindful Courage
Keywords
Anorexia Nervosa, Bulimia Nervosa, Mindfulness Training, Digital Intervention
Medical subject headings
Anorexia Nervosa, Bulimia Nervosa, Bulimia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindful CourageBehavioural

    Self-guided online intervention

Study groups in NCT05753410
Study groupRoleWhat they receive
Mindful CourageExperimentalMindful Courage is a digital intervention including mindfulness and cognitive behavioral elements for individuals with anorexia nervosa or bulimia nervosa. Mindful Courage will consist of 8-weeks of self-guided modules which will be completed over the course of 8 weeks. Elements included in the intervention include psychoeducation, self-monitoring, regular eating, body image, values clarification, and mindful awareness and acceptance. Participants learn a range mindfulness skills and practice a range of mindfulness meditations. Participants will also receive phone coaching. Homework consists of meditation practices.
Receives: Behavioral: Mindful Courage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of Module Completion

    Module completion, ranging from 0 to 100%

    Measured: 8-week treatment period

  2. Acceptability Dimensions

    Single-items measuring ratings of acceptability dimensions, including usability, understandability, engage-ability, visual appeal, helpfulness, skill acquisition, and confidence implementing skills ratings. Scores for each item range from 1 to 5 and are averaged, with higher scores indicating better acceptability.

    Measured: 8-week treatment period

Secondary outcomes (6)
  1. Change in Eating Disorder Symptoms

    Eating Disorder Examination-Questionnaire (EDE-Q). Total scores are the average of each of the subscales, and range from 0 to 6. Higher scores indicate higher eating disorder symptoms.

    Measured: Baseline through 2-month follow-up

  2. Change in Emotion Dysregulation

    Difficulties in Emotion Regulation Short Form (DERS-SF). Total scores are the average of each of the subscales, and range from 1 to 5. Higher scores indicate more emotion dysregulation

    Measured: Baseline through 2-month follow-up

  3. Change in Body Dissatisfaction

    Body Shape Questionnaire (BSQ). Total scores are the total across the items, and range from 34 to 204. Higher scores indicate greater body dissatisfaction.

    Measured: Baseline through 2-month follow-up

  4. Savoring Beliefs

    Savoring Beliefs Inventory (SBI). Total scores are the total across the positively-anchored and negatively-anchored items, and could range from -72 to 72. Higher scores reflect stronger endorsement of savoring beliefs.

    Measured: Baseline through 2-month follow-up

  5. Psychosocial Impairment

    Clinical Impairment Assessment Questionnaire (CIA). Total scores are the total of the items, and range from 0 to 48. Higher scores indicate greater psychosocial impairment associated with an eating disorder.

    Measured: Baseline through 2-month follow-up

  6. Change in Mindfulness

    Cognitive and Affective Mindfulness Scale-Revised (CAMS-R). Total scores range from 0 to 40, with higher scores indicating greater mindfulness.

    Measured: Baseline through 2-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2023
  2. Study start1 Mar 2023
  3. Primary completion1 Jan 2025
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05753410
Sponsor's protocol ID
20204635
Status last verified
Mar 2026
First submitted
21 Feb 2023
Last updated
16 Apr 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Mindful Courage in people with Anorexia Nervosa and Bulimia Nervosa, run by Yeshiva University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 16 Apr 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of Module Completion (time frame: 8-week treatment period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in